Background image

Timeline

In 1948, a group of pharmacists in Ballina, a small town in the West of Ireland established United Drug Chemical Co. 1989 saw United Drug listed on the Irish Stock Market. In 1999, the acquisition of Sangers, a wholesale company in Northern Ireland meant United Drug had an all-Ireland distribution service.

Since 2000, our strategic focus has been to transition our organisation from demand fulfilment to demand creation and expand our geographical footprint. A critical element in the execution of this strategy has been making the right acquisitions to help us to build, expand and grow our capabilities, territories and leadership positions.

2000
Company logo

Ashfield Healthcare

Acquired in 2000, Ashfield Healthcare marked our entry into the contract sales market in the UK and Ireland.

2002
Company logo

Ventiv Health

Ashfield expanded their UK contract sales (CSO) with the acquisition of Ventiv Health.

2005
Company logo

In2Focus

The acquisition of In2Focus and subsequent integration of Ashfield and In2Focus created Ashfield In2Focus, the UK and Ireland’s No.1 Contract Sales Organisation.

2007
Company logo

Alliance Healthcare

Acquired in 2007, Alliance Healthcare was a complimentary acquisition of medical call centre capabilities to strengthen US footprint and increase organic growth.

2007
Company logo

Move into contract packaging

In 2007, UDG Healthcare made its first move into the contract packaging industry with the acquisition of packaging plants in Belgium (Budelpack International) and the Netherlands (Pharma Logistics Investments BV).

2007
Company logo

Procon

Finally in 2007, the acquisition of Procon in the UK meant we entered into the growing healthcare events market.

2008
Company logo

Sharp Corporation

2008 saw the acquisition of Sharp Corporation, with its state-of-the-art packaging facilities, in the US.

2008
Company logo

Business Edge 

Pharma leadership and sales training services strengthened Ashfield’s CSO offering.

2008
Company logo

Universal

Ashfield’s Meetings & Events capability could now serve the US and the UK healthcare markets with the acquisition of Universal.

2010
Company logo

InforMed

In 2010, we entered the global healthcare communications market with the acquisition of InforMed.

2010
Company logo

WorldEvents

The acquisition of WorldEvents in 2010 made us the world’s No.1 specialist provider of international healthcare meetings and events.

2012
Company logo

Pharmexx

Through the acquisition of Pharmexx, we added true international reach and depth to our contract sales capabilities through our expansion into 8 new countries. 

2012
Company logo

Bilcare

The acquisition of Bilcare in the US and the UK added clinical trial and supply chain packaging expertise to our packaging portfolio.

FTSE Listing

In 2012, we moved our listing from the Irish Stock Exchange to the London Stock Exchange entering as a FTSE 250 organisation.

2012
Company logo

Watermeadow, Drug Safety Alliance and Synopia

Our final three acquisitions of 2012 were WaterMeadow Medical, Drug Safety Alliance and Synopia RX.

2013
Company logo

Launch of UDG Healthcare

In 2013, we changed our name from United Drug to UDG Healthcare plc.

2013
Company logo

Medical Communications Group

The acquisition of Medical Communications Group (MCG), a Canadian based commercial services provider strengthened our offering in Canada.

2013
Company logo

Expansis

This Spanish CSO depended Ashfield’s commercial presence in Europe.

2014
Company logo

KnowledgePoint360

KnowledgePoint360 is our largest acquisition to date, making Ashfield a global market leader in healthcare communications.

2014
Company logo

Galliard and Nyxeon

The acquisition of Galliard and Nyxeon in 2014, diversified our healthcare communications portfolio to include scientific PR.

2014
Company logo

Disposal of UniDrug Distribution Group

We also sold our 50% share in UniDrug Distribution Group.

2015
Company logo

CMIC Ashfield

We formalised our joint venture with CMIC in 2015, creating CMIC Ashfield, a contract sales solution in Japan.

Sharp US Facility Expansion

We acquired a new site and invested in expanding our Sharp US facility.

2016
Company logo

Disposal of United Drug

In 2016, we completed the sale of the United Drug Supply Chain businesses and MASTA to McKesson, the culmination of 15 years of strategic development by the Group.

2016
Company logo

Pegasus

In 2016, we acquired Pegasus, one of the most successful integrated healthcare communications consultancies in the UK.

2016
Company logo

STEM Marketing

The acquisition of STEM Marketing was our first move into the Advisory space. STEM are the leading global provider of commercial, marketing and medical audits to pharmaceutical companies.

2017
Company logo

Sellxpert

We acquired Sellxpert, a German and Swiss contract sales outsourcing business, based in Speyer, Germany and Basel, Switzerland, cementing our footprint in the DACH region.

2017
Company logo

Vynamic

The acquisition of Vynamic, a US-based healthcare industry management consultancy, further strengthened and expanded our Advisory offering.

2017
Company logo

Cambridge Biomarketing

We acquired Cambridge Biomarketing, a full-service advertising and communications agency focused on orphan diseases and specialty markets.

 

2017
Company logo

MicroMass Communications

Our final acquisition of 2017 was the acquisition of MicroMass Communications, a US-based healthcare communications agency specialising in behavioural change